News

A new device combines high-resolution PET with SPECT scanners to allow scientists working on cancer and brain research with small animals to see functional details down to a half millimeter in size.

Dubbed the Versatile Emission Computed Tomography, or VECTor, the device, developed by researchers at the Delft University of Technology in the Netherlands and the company Molecular Imaging Labs, could help scientists find cancer treatments

TU Delft and Molecular Imaging Labs (MI Labs) have succeeded in combining two forms of medical imaging techniques into one piece of equipment. These techniques are particularly useful for cancer research. The two techniques are known as microPET and microSPECT.   SPECT and PET can be performed simultaneously and they give a higher resolution than traditional microSPECT and microPET. The new device is known as the VECTor (Versatile Emission Computed Tomography) and is designed for use in fundamental research into the functioning of cells and organs. It can show functional details smaller than half a millimetre.

Dutch researchers using preclinical imagers U-SPECT from MILabs of Utrecht, The Netherlands, and Inveon PET from Siemens Healthcare of Knoxville TN, said the imaging methods allowed them to successfully and noninvasively visualize the insulinlike growth factor 1 receptor among animal subjects with triple-negative breast cancer. Being able to image the receptor could improve patient selection from the triple-negative breast cancer patient population for targeted treatment using IGF-1R antibodies, an expert said.

At the 2009 Annual Society of Nuclear Medicine meeting in Toronto from June 13 till 16, MILabs introduces its novel U-SPECT/CT system, the state-of-the-art Micro-SPECT system offering the highest resolution available that is fully integrated with the MILabs high throughput, low dose U-CT. In the run up to the launch MILabs’ has already contracted to sell one U-SPECT/CT system and upgrade an existing U-SPECT to a fully integrated U-SPECT/ CTsystem.

Highest resolution SPECT in the world now available with integrated X-ray CT.

NGP gathers industry experts of Cisbio, MILabs, PerkinElmer and Roche to discuss the current drug development space.

Milabs introduces a novel  tool U-Overlay™ which allows fast field-of-view selection based on the projections of 3D mouse anatomy.